AAAAAA

   
Results: 1-25 | 26-46 |
Results: 26-46/46

Authors: Aukrust, P Muller, F Ueland, T Svardal, AM Berge, RK Froland, SS
Citation: P. Aukrust et al., Decreased vitamin A levels in common variable immunodeficiency: vitamin A supplementation in vivo enhances immunoglobulin production and downregulates inflammatory responses, EUR J CL IN, 30(3), 2000, pp. 252-259

Authors: Muller, F Svardal, AM Nordoy, I Berge, RK Aukrust, P Froland, SS
Citation: F. Muller et al., Virological and immunological effects of antioxidant treatment in patientswith HIV infection, EUR J CL IN, 30(10), 2000, pp. 905-914

Authors: Nordoy, I Muller, F Nordal, KP Rollag, H Aukrust, P Froland, SS
Citation: I. Nordoy et al., Chemokines and soluble adhesion molecules in renal transplant recipients with cytomegalovirus infection, CLIN EXP IM, 120(2), 2000, pp. 333-337

Authors: Stylianou, E Aukrust, P Bendtzen, K Muller, F Froland, SS
Citation: E. Stylianou et al., Interferons and interferon (IFN)-inducible protein 10 during highly activeanti-retroviral therapy (HAART) - possible immunosuppressive role of IFN-alpha in HIV infection, CLIN EXP IM, 119(3), 2000, pp. 479-485

Authors: Damas, JK Eiken, HG Oie, E Bjerkeli, V Yndestad, A Ueland, T Tonnessen, T Geiran, OR Aass, H Simonsen, S Christensen, G Froland, SS Attramadal, H Gullestad, L Aukrust, P
Citation: Jk. Damas et al., Myocardial expression of CC- and CXC-chemokines and their receptors in human end-stage heart failure, CARDIO RES, 47(4), 2000, pp. 778-787

Authors: Damas, JK Gullestad, L Ueland, T Solum, NO Simonsen, S Froland, SS Aukrust, P
Citation: Jk. Damas et al., CXC-chemokines, a new group of cytokines in congestive heart failure - possible role of platelets and monocytes, CARDIO RES, 45(2), 2000, pp. 428-436

Authors: Torfoss, D Aukrust, P Brinch, L Mathiesen, O Simonsen, GS Axelsen, AK Gaustad, P
Citation: D. Torfoss et al., Carrier rate of resistant enterococci in a tertiary care hospital in Norway, APMIS, 107(6), 1999, pp. 545-549

Authors: Aukrust, P Muller, F
Citation: P. Aukrust et F. Muller, Glutathione redox disturbances in human immunodeficiency virus infection: Immunologic and therapeutic consequences, NUTRITION, 15(2), 1999, pp. 165-167

Authors: Gullestad, L Aukrust, P Ueland, T Espevik, T Yee, G Vagelos, R Froland, SS Fowler, M
Citation: L. Gullestad et al., Effect of high- versus low-dose angiotensin converting enzyme inhibition on cytokine levels in chronic heart failure, J AM COL C, 34(7), 1999, pp. 2061-2067

Authors: Kvale, D Aukrust, P Osnes, K Muller, F Froland, SS
Citation: D. Kvale et al., CD4+ and CD8+ lymphocytes and HIV RNA in HIV infection: high baseline counts and in particular rapid decrease of CD8+ lymphocytes predict AIDS, AIDS, 13(2), 1999, pp. 195-201

Authors: Aandahl, EM Aukrust, P Muller, F Hansson, V Tasken, K Froland, SS
Citation: Em. Aandahl et al., Additive effects of IL-2 and protein kinase A type I antagonist on function of T cells from HIV-infected patients on HAART, AIDS, 13(17), 1999, pp. F109-F114

Authors: Nordoy, I Muller, F Nordal, KP Rollag, H Lien, E Aukrust, P Froland, SS
Citation: I. Nordoy et al., Immunologic parameters as predictive factors of cytomegalovirus disease inrenal allograft recipients, J INFEC DIS, 180(1), 1999, pp. 195-198

Authors: Aukrust, P Muller, F Lien, E Nordoy, I Liabakk, NB Kvale, D Espevik, T Froland, SS
Citation: P. Aukrust et al., Tumor necrosis factor (TNF) system levels in human immunodeficiency virus-infected patients during highly active antiretroviral therapy: Persistent TNF activation is associated with virologic and immunologic treatment failure, J INFEC DIS, 179(1), 1999, pp. 74-82

Authors: Aukrust, P Aandahl, EM Skalhegg, BS Nordoy, I Hansson, V Tasken, K Froland, SS Muller, F
Citation: P. Aukrust et al., Increased activation of protein kinase a type I contributes to the T cell deficiency in common variable immunodeficiency, J IMMUNOL, 162(2), 1999, pp. 1178-1185

Authors: Aukrust, P Haug, CJ Ueland, T Lien, E Muller, F Espevik, T Bollerslev, J Froland, SS
Citation: P. Aukrust et al., Decreased bone formative and enhanced resorptive markers in human immunodeficiency virus infection: Indication of normalization of the bone-remodeling process during highly active antiretroviral therapy, J CLIN END, 84(1), 1999, pp. 145-150

Authors: Aukrust, P Gullestad, L Froland, SS
Citation: P. Aukrust et al., Is apoptosis an important pathogenic factor in cardiovascular disease?, EUR J CL IN, 29(5), 1999, pp. 369-371

Authors: Stylianou, E Aukrust, P Kvale, D Muller, F Froland, SS
Citation: E. Stylianou et al., IL-10 in HIV infection: increasing serum IL-10 levels with disease progression - down-regulatory effect of potent anti-retroviral therapy, CLIN EXP IM, 116(1), 1999, pp. 115-120

Authors: Aukrust, P Muller, F Svenson, M Nordoy, I Bendtzen, K Froland, SS
Citation: P. Aukrust et al., Administration of intravenous immunoglobulin (IVIG) in vivo-down-regulatory effects on the IL-1 system, CLIN EXP IM, 115(1), 1999, pp. 136-143

Authors: Aukrust, P Muller, F Ueland, T Berget, T Aaser, E Brunsvig, A Solum, NO Forfang, K Froland, SS Gullestad, L
Citation: P. Aukrust et al., Enhanced levels of soluble and membrane-bound CD40 ligand in patients withunstable angina - Possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes, CIRCULATION, 100(6), 1999, pp. 614-620

Authors: Gullestad, L Simonsen, S Ueland, T Holm, T Aass, H Andreassen, AK Madsen, S Geiran, O Froland, SS Aukrust, P
Citation: L. Gullestad et al., Possible role of proinflammatory cytokines in heart allograft coronary artery disease, AM J CARD, 84(9), 1999, pp. 999-1003

Authors: Aukrust, P Ueland, T Lien, E Bendtzen, K Muller, F Andreassen, AK Nordoy, I Aass, H Espevik, T Simonsen, S Froland, SS Gullestad, L
Citation: P. Aukrust et al., Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy, AM J CARD, 83(3), 1999, pp. 376-382
Risultati: 1-25 | 26-46 |